The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Cloud and AI in Pharma: Driving Digital Transformation in Pharmaceutical Operations
Read More
post
Biopharma M&A in 2026: Key Trends, Deal Drivers, and Strategic Outlook
Read More
case-study
The Journey Leading to an Approved NDA
Read More
infographic
Early CMC Decisions that Shape IND Readiness
Read More
Let's move from science to success.
Let’s Talk